Polymorphonuclear leukocyte motility in vitro. VI. Effect of purine and pyrimidine analogues: possible role of cyclic AMP.
D000225:Adenine / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology; D000242:Cyclic AMP / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D004837:Epinephrine / Q000494:pharmacology; D006147:Guanine / Q000494:pharmacology; D006151:Guanosine / Q000494:pharmacology; D006801:Humans; D007042:Hypoxanthines / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D007962:Leukocytes / Q000187:drug effects* / Q000502:physiology; D009068:Movement / Q000187:drug effects; D011687:Purines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013806:Theophylline / Q000494:pharmacology; D013941:Thymine / Q000494:pharmacology; D014498:Uracil / Q000494:pharmacology; D014527:Uric Acid / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology
D007042:Hypoxanthines; D007093:Imidazoles; D011687:Purines; D011743:Pyrimidines; D014970:Xanthines; D006151:Guanosine; D014527:Uric Acid; D002110:Caffeine; D014498:Uracil; D006147:Guanine; D012110:Reserpine; D013806:Theophylline; D000242:Cyclic AMP; D000225:Adenine; D013941:Thymine; D004837:Epinephrine